NCT06156670Recruiting
Russian Registry of Endovascular Closure of PFO
Russian Registry of Endovascular Closure of Patent Foramen Ovale
Source: ClinicalTrials.gov · Last updated 29 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
The study will include all patients over 18 years of age who underwent endovascular closure of patent foramen ovale in medical centers in the Russian Federation, who gave written informed consent to the closure and provided personal data as part of inpatient medical care. The project participants will be 29 medical centers in the Russian Federation, where endovascular closure of patent foramen ovale is performed.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 700 (estimated)
- First submitted
- 27 Nov 2023
- Start date
- 1 Dec 2023
- Primary completion date
- 31 Dec 2025
- Lead sponsor
- National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
- Diseases
- Stroke
- NCT number
- NCT06156670
What you commit to
- Study type: Observational
- Planned participants: 700
- From 1 Dec 2023 to the primary completion date, 31 Dec 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Inability to receive antiplatelet therapy;
- Myocardial infarction or aortocoronary bypass surgery within the previous 30 days;
Other illness
- Presence of acute inflammatory diseases;
- Acute stage of cerebral circulatory failure (30 days);
- Severe cardiac valve pathology;
- Presence of blood clots in the cardiac cavities;
Other
- Carotid or vertebral artery dissection;
- Refusal of the patient to participate in the study.
Who the study is looking for
- Patients with an ischemic event (cryptogenic ischemic stroke, transient ischemic attack, embolism of other organs and systems) associated with a PFO;
- Presence of an open oval confirmed by ultrasound diagnostic methods;
- Age of patients from 18 years;
- Life expectancy of at least 1 year;
- Signed informed consent for endovascular closure of a PFO.
Age in the registry: 18 years to 70 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| National Medical Research Center for Cardiology, Ministry of Health of Russian Federation Coordinator of this site? Confirm its status | Moscow | Russia | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.